20 years helping business leaders deliver alpha. View our success stories
20 years helping business leaders deliver alpha. View our success stories
By Humatica
Humatica AG was retained to advise Capvis on its majority investment in Austrian firm AMANN GIRRBACH AG, a pioneer in dental CAD/CAM technology. The firm is a leading innovator in the field and a full-service provider for digital dental prosthetics.
Humatica provided organisational due diligence services for this transaction.
To view press release: Humatica advises Capvis on their recent investment in AMANN GIRRBACH
Humatica is pleased to announce two senior level promotions, reflecting continued growth and the strengthening of its leadership team. Paul Simpson, based in Zurich, has…
Read more
Humatica has once again been short-listed for Actum’s 2026 Value Creation Award in the People & Organisational Strategy category. This recognition reflects Humatica’s 23‑year commitment…
Read more
Humatica is once again shortlisted for Real Deals’ prestigious Private Equity Awards 2026 in the “Value Creation Adviser of the Year” category. This recognition underscores…
Read more
